Profiel
Taro Tokita is currently working as a Director at ARTham Therapeutics, Inc. and as a Representative Director at RBG Partners KK.
Previously, he worked as an Executive Officer Second Investment Director at SMBC Venture Capital KK from 2006 to 2018.
Actieve functies van Taro Tokita
| Bedrijven | Functie | Begin |
|---|---|---|
RBG Partners KK
 RBG Partners KK Investment ManagersFinance RBG Partners KK engages in the operation and management of investment business partnership assets. It also deals with the acquisition and holding of securities and offers consulting services for company diagnosis and investment planning. The company was founded on October 2, 2018 and is headquartered in Yokohama, Japan. | Directeur/Bestuurslid | - |
ARTham Therapeutics, Inc.
 ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Taro Tokita
| Bedrijven | Functie | Einde |
|---|---|---|
SMBC Venture Capital KK
 SMBC Venture Capital KK Investment ManagersFinance SMBC Venture Capital KK (SMBC Venture Capital) is a Private Equity firm, a subsidiary of Sumitomo Mitsui Banking Corp., itself a subsidiary of publicly traded company Sumitomo Mitsui Financial Group, Inc. (TK:8316) founded in 2005. The firm is headquartered in Tokyo. | Private Equity Investor | 31-12-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
SMBC Venture Capital KK
SMBC Venture Capital KK Investment ManagersFinance SMBC Venture Capital KK (SMBC Venture Capital) is a Private Equity firm, a subsidiary of Sumitomo Mitsui Banking Corp., itself a subsidiary of publicly traded company Sumitomo Mitsui Financial Group, Inc. (TK:8316) founded in 2005. The firm is headquartered in Tokyo. | Finance |
RBG Partners KK
RBG Partners KK Investment ManagersFinance RBG Partners KK engages in the operation and management of investment business partnership assets. It also deals with the acquisition and holding of securities and offers consulting services for company diagnosis and investment planning. The company was founded on October 2, 2018 and is headquartered in Yokohama, Japan. | Finance |
ARTham Therapeutics, Inc.
ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Health Technology |
